Boston Scientific ’s Resonate Cardiac Implants with HeartLogic Predict Adverse Events, Now FDA Approved

Boston Scientific won approval from the FDA and is launching its Resonate line of implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy defibrillators (CRT-D). The implants include the firm’s HeartLogic diagnost...
Source: Medgadget - Category: Medical Devices Authors: Tags: Cardiology Medicine Source Type: blogs